Robert Dee Etherington
Vorstandsvorsitzender bei CLENE INC.
Vermögen: 32 726 $ am 30.04.2024
Aktive Positionen von Robert Dee Etherington
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CLENE INC. | Direktor/Vorstandsmitglied | 01.01.2020 | - |
Vorstandsvorsitzender | 01.04.2013 | - | |
Präsident | 01.04.2013 | - | |
BioUtah | Direktor/Vorstandsmitglied | 01.06.2016 | - |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 01.04.2013 | - | |
Präsident | 01.04.2013 | - | |
Corsair LLC | Direktor/Vorstandsmitglied | 01.03.2018 | - |
Karriereverlauf von Robert Dee Etherington
Ehemalige bekannte Positionen von Robert Dee Etherington
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Vertrieb & Marketing | 01.09.2000 | 01.03.2013 |
Ausbildung von Robert Dee Etherington
Brigham Young University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Schweiz | 2 |
Operativ
Director/Board Member | 4 |
Chief Executive Officer | 2 |
President | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CLENE INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
BioUtah | |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Health Technology |
Corsair LLC |
- Börse
- Insiders
- Robert Dee Etherington
- Erfahrung